We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Katten‘s ’patent litigation practice specializes in Hatch-Waxman cases for leading generic drug companies. Recently, the team worked on a high-profile case representing Sun Pharmaceutical Industries in defending their generic version of Ozempic. Deepro Mukerjee, based in New York, is ‘a stand-out patent litigator’ who oversees trial and appellate proceedings. Mukerjee also has experience managing IPR proceedings before the PTAB. Mukerjee chairs the department alongside New-York-based Lance Soderstrom, a seasoned litigator with expertise in pharmaceutical compounds and medical devices, and Chicago-based Brian Sodikoff, who also focuses on Hatch-Waxman patent litigation, drawing on his background in competition law.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Extremely competent group of attorneys, led by Mr Deepro Mukerjee. They use common sense, value-driven billing with an eye towards results.’
‘Mr. Deepro Mukerjee is a stand-out patent litigator, immensely talented and results-driven, and leader of the patent litigation team at Katten. He has a keen understanding of his client's business needs and focuses his advice on a legal and business perspective. ’
Key clients
- Apotex Corp. / Apotex Inc.
- Avocados Plus
Work highlights
- Representing Sun Pharmaceutical Industries (Sun) in a patent lawsuit involving Ozempic, a popular diabetes drug that people also take for weight loss.
- Representing Sun Pharmaceutical Industries (Sun) in a patent lawsuit involving Wegovy, an injectable weight-loss medication for adults with obesity or excess weight with weight-related conditions.